Comprehensive Seminar Notes on Colorectal and Anal Disorders

Anatomy of the Large Bowel and Rectum

  • Vascular Supply of the Colon:

    • Superior Mesenteric Artery (SMA): Supplies the right side (ascending colon and right half of the transverse colon).

      • Middle Colic Artery: Supplies the transverse colon.

      • Right Colic Artery: Supplies the ascending colon.

      • Ileocolic Artery: Supplies the cecum and appendix.

    • Inferior Mesenteric Artery (IMA): Supplies the left side (left half of the transverse colon, descending colon, and sigmoid colon).

      • Left Colic Artery: Has ascending and descending branches.

      • Sigmoid Arteries: Supply the sigmoid colon.

      • Superior Rectal Artery: The terminal branch of the IMA.

    • Marginal Artery (of Drummond): Provides collateral circulation between the SMA and IMA systems.

  • Arteries of the Rectum and Anal Canal:

    • Superior Rectal Artery: Branch from the Inferior Mesenteric Artery.

    • Middle Rectal Artery: Branch from the Internal Iliac Artery.

    • Inferior Rectal Artery: Branch from the Internal Pudendal Artery (which exits the Pudendal Canal/Alcock's canal near the ischial tuberosity).

    • Median Sacral Artery: A small branch arising from the abdominal aorta just above the bifurcation.

  • Muscular Anatomy:

    • Internal Anal Sphincter Muscle: An extension of the circular smooth muscle layer of the rectum (involuntary).

    • External Anal Sphincter Muscle: Comprising deep, superficial, and subcutaneous parts (voluntary).

    • Levator Ani Muscle: Supports the pelvic floor; consists of the puborectalis, pubococcygeus, and iliococcygeus muscles.

Lower Gastrointestinal (GI) Bleeding

  • Epidemiology:

    • Lower GI bleeding has an annual incidence of 2020 to 2727 cases per 100,000100,000 population.

  • Etiologies and Clinical Presentations:

    • Ischemic Colitis: Characterized by sudden onset of left-sided abdominal pain followed by bloody diarrhea. It is often secondary to conditions like hemodialysis, myocardial infarction, postcardiopulmonary bypass, or postaortoiliac surgery. It predominantly affects the mucosa.

    • Hemorrhoids: Bright red blood on toilet paper or the bowl; rarely hemodynamically significant.

    • Inflammatory Bowel Disease (IBD): Small amounts of blood mixed with mucus and feces.

    • Tumors: Color becomes brighter as the tumor location moves from proximal to distal colon.

    • Diverticular Disease and Angiodysplasia: Typically sudden, brisk, but self-limiting bleeding. Diverticular bleeding occurs when a vessel breaks down as it passes through the weakened diverticulum wall. Angiodysplasia involves age-related degeneration of submucosal veins.

    • Brisk Upper GI Bleed: Can present as bright red blood per rectum if transit is very rapid.

  • Diagnostic Procedures:

    • Nasogastric (NG) Tube Placement: Used to rule out an upper GI source. If clear bilious fluid is aspirated, the source is likely distal to the Ligament of Treitz.

    • Colonoscopy: The definitive diagnostic tool for ischemic colitis and visualizing polyps/tumors.

    • Computed Tomography (CT): May reveal colonic wall thickening, pneumatosis, or portal venous gas in severe ischemic cases.

    • Technetium-99m99m Sulphur Colloid Isotope Red Cell Scan: Most sensitive; detects extravasation with bleeding as low as 0.050.05 to 0.1ml/min0.1\,ml/min.

  • Management Strategies:

    • Minor Bleeding: History, physical exam, anorectal exam, anoscopy, proctosigmoidoscopy, and colonoscopy.

    • Major Bleeding:

      • Resuscitation first.

      • Surgery indicated if hemodynamic instability persists or if patients require more than 66 units of red blood cells in 2424 hours.

      • Segmental Resection: Ideal if the segment is localized.

      • Total Abdominal Colectomy with Ileorectal Anastomosis: For uncontrolled, nonlocalized bleeding.

    • Diverticular Bleeding Management: 90%90\% stop bleeding spontaneously; supportive care (fluids/transfusion) is usually sufficient. Recurrent bleeding requires resection.

Diverticular Disease

  • Pathophysiology:

    • Mucosal outpouchings through the submucosa and muscular layer.

    • Usually occur between the antimesenteric taenia and mesenteric taenia at the site where blood vessels enter the wall.

    • Sigmoid colon is involved in nearly all cases; 10%10\% involve the entire colon.

  • Epidemiology: An acquired condition associated with consumption of refined foods and low dietary fiber (rare in rural Africa and Asia).

  • Clinical Definitions:

    • Diverticulosis: Presence of noninflamed diverticula (may be asymptomatic or cause colicky pain).

    • Diverticulitis: Inflammation of one or more diverticula.

  • Management of Complications:

    • Acute Diverticulitis/Phlegmon: IV fluids, antibiotics, and bowel rest.

    • Abscess: Percutaneous drainage under CT guidance.

    • Fecal Peritonitis: Emergency laparotomy. The standard procedure is the Hartmann Procedure (resection of sigmoid colon, proximal stoma, and oversewn rectal stump).

    • Hinchey Classification:

      • Hinchey I: Pericolic or mesenteric abscess.

      • Hinchey II: Contained pelvic abscess.

      • Hinchey III: Generalised purulent peritonitis.

      • Hinchey IV: Generalised feculent peritonitis (mortality rate approximately 50%50\%).

    • Fistulae: Common sites include erosion into adjacent viscera (e.g., bladder).

Ulcerative Colitis (UC)

  • Epidemiology: 11 to 1515 new cases per 100,000100,000 population annually. Bimodal distribution (teens and early 40s40s).

  • Pathology:

    • The disease is limited to the mucosa and submucosa.

    • Continuous involvement: The rectum is always involved; spreads proximally.

    • Macroscopic: Ulcerated mucosa with pseudopolyps (regenerating mucosa).

    • Microscopic: Crypt abscesses at the base of the mucosa.

  • Clinical Features:

    • Frequent blood-stained stools or diarrhea with mucus.

    • Tenesmus and lower abdominal pain.

    • 20%20\% of patients suffer a severe attack/pancolitis (unremitting bloody diarrhea 1010 to 2424 times per day).

  • Medical Management:

    • Aminosalicylic acid (5-ASA): Mainstay; linked with stabilizing compounds to release at high pH in the colon. Used to induce and maintain remission.

    • Steroids: For moderate to severe cases; not for maintenance of remission.

    • Biologic Agents/Immunomodulators: For resistant disease.

  • Surgical Management:

    • Indications: Intractability, high-grade dysplasia/cancer risk (surveillance begins 1010 years after diagnosis, every 33 years), hemorrhage, perforation, or toxic dilatation.

    • Total Proctocolectomy: Gold standard for cure; requires a permanent Brooke ileostomy.

    • Restorative Proctocolectomy (J-Pouch): Creation of an ileal reservoir to replace the rectum. Complications include pouchitis, stricture, and sexual dysfunction.

Comparison: Ulcerative Colitis vs. Crohn Disease

  • Ulcerative Colitis:

    • Location: Colon only.

    • Lesions: Continuous from rectum.

    • Inflammation: Mucosa/Submucosa (shallow).

    • Neoplasms: High risk.

    • Fistulae/Fissures/Granulomas: None.

  • Crohn Disease:

    • Location: Entire GI tract.

    • Lesions: Skip lesions.

    • Inflammation: Transmural (full thickness).

    • Neoplasms: Lower risk.

    • Fistulae: Frequent.

    • Fissures: Through submucosa.

    • Granulomas: Noncaseating.

Colorectal Polyps

  • Epidemiology: Found in 20%20\% to 40%40\% of asymptomatic patients over 5050. 30%30\% to 50%50\% with one adenoma have a synchronous one elsewhere.

  • Neoplastic Mucosal Polyps (Adenomas):

    • Precursors to 70%70\% of all colorectal cancers (CRC).

    • Cancer Risk Factors: Size (polyps > 2\,cm have a 30%40%30\%-40\% malignancy risk; < 1\,cm have 1%2%1\%-2\%), degree of dysplasia, and villous architecture.

    • Types: Tubular (75%75\%), Tubulovillous (15%15\%), Villous (10%10\%).

    • Physical Structure: Sessile (broad-based) or Pedunculated (on a stalk).

  • Non-neoplastic Polyps:

    • Hyperplastic: Small, sessile, no malignant potential. Found in 1/31/3 of population over 5050.

    • Juvenile (Retention) Polyps: Common in children (<10 years old). No individual malignant potential but can cause bleeding or intussusception.

    • Inflammatory Polyps: Associated with IBD.

  • Management: All polyps must be removed via endoscopic polypectomy or segmental resection if too large/suspicious.

Colorectal Cancer (CRC)

  • Incidence: 3rd most common tumor in men, 2nd in women; accounts for 10%10\% of all tumor types and 8%8\% of cancer deaths worldwide.

  • Risk Factors: Age > 40, family history, inherited syndromes (FAP < 1\%, Lynch/HNPCC 3%5%3\%-5\%), chronic IBD, and pelvic radiation.

  • Symptoms by Site:

    • Right Colon: Iron deficiency anemia, weight loss, dull abdominal pain.

    • Left Colon/Sigmoid: Change in bowel habits (constipation/diarrhea), colicky pain, obstructive symptoms.

    • Rectum: Rectal fullness, urgency, tenesmus, bleeding, pelvic pain.

  • Diagnosis and Staging:

    • Screening: FOBT (can have false positives from red meat/peroxidase), FIT, Colonoscopy (every 1010 years for average risk), CT Colonography.

    • Carcinoembryonic Antigen (CEA): Useful for postoperative follow-up; low predictive value for initial diagnosis.

    • TNM Classification:

      • Tis: Carcinoma in situ.

      • T1: Invades submucosa.

      • T2: Invades muscularis propria.

      • T3: Invades through muscularis into pericolorectal tissues.

      • T4a: Penetrates visceral peritoneum.

      • T4b: Invades other organs.

      • N1: Metastasis in 131-3 regional nodes.

      • N2: Metastasis in 4+4+ regional nodes.

      • M1a: Metastasis in one organ.

      • M1b: Metastasis in multiple organs/peritoneum.

    • Staging Note: At least 1212 lymph nodes must be examined for adequate pN staging.

  • Management:

    • Surgery: Wide resection (at least 5cm5\,cm margins) and lymph node removal.

    • Adjuvant Therapy: Recommended for Stage III and high-risk Stage II. Includes 5-FU/FA or Oxaliplatin combinations (FOLFOX, XELOX).

    • Follow-up: recurrences likely within 1818 months (50%50\%) to 33 years (90%90\%).

Specialty Tumors and Anal Disorders

  • Carcinoid Tumors: Rectal carcinoids are usually submucosal yellow-gray nodules. Small lesions ( < 1\,cm) are treated with local transanal excision. Large lesions ( > 2\,cm) are malignant.

  • Anal Cancer:

    • Squamous Cell Carcinoma (SCC): Grows slowly, drains to inguinal lymph nodes. Local excision unless invading sphincter.

    • Basal Cell Carcinoma: Rare; locally excised.

  • Hemorrhoids:

    • Downward displacement of anal cushions (left lateral, right anterior, right posterior).

    • Grading:

      • 1st Degree: No prolapse.

      • 2nd Degree: Prolapse with spontaneous reduction.

      • 3rd Degree: Prolapse requiring manual replacement.

      • 4th Degree: Permanently prolapsed, irreducible.

    • Treatment: Rubber band ligation (1st-3rd), Hemorrhoidectomy (4th or complicated), and Stapled Hemorrhoidopexy.

  • Anal Fissure: An ulcer in the lower anal canal, usually in the posterior midline. Fissure triad: Chronic fissure, sentinel skin tag, and hypertrophied anal papilla. Treatment: Lateral internal sphincterotomy.

  • Anorectal Abscess: Results from infection of anal glands. Classified as Perianal (most common), Ischiorectal, Intersphincteric, or Supralevator. Treatment: Primary incision and drainage.

  • Fistula in Ano: Chronic inflammatory tract connecting anal crypt to perianal skin. Management: Fistulotomy (unroofing the tract).

  • Pilonidal Sinus: Infection of a hair follicle in the sacrococcygeal area, most common in high-hirsute patients in their 20s30s20s-30s. Treatment: Drainage and local excision.

Questions & Discussion

  • Clinical Case 1: A 30-year-old female with colitis in transverse/descending colon. BIopsy shows inflammatory process confined to mucosa and submucosa. Diagnosis: Ulcerative Colitis.

  • Clinical Case 2: A 28-year-old with hematochezia, negative endoscopy, blood noted above ileocecal valve. Test of choice: Technetium 99m99m pertechnetate scan (to look for Meckel's diverticulum/ectopic gastric mucosa).

  • Clinical Case 3: 4-cm carcinoid mass found in appendix during appendectomy. Correct management: Right hemicolectomy (masses > 2\,cm require radical resection).

  • Clinical Case 4: Correct use of CEA: To monitor for postoperative recurrence.

  • Surgical Matches:

    1. 37-year-old with UC and high-grade dysplasia rectally: Total proctocolectomy with ileoanal J-pouch.

    2. 60-year-old with recurrent anal SCC after chemoradiation: Abdominoperineal resection.

    3. 68-year-old with fixed adenocarcinoma 3cm3\,cm from anal verge and incontinence: Abdominoperineal resection.

    4. 33-year-old with Crohn, tachycardia, fever, and dilated colon: Subtotal colectomy with end ileostomy (Emergency treatment for toxic megacolon/perforation).